Indications and uses
To assist with balancing the terrain associated with sensitivities
To assist with balancing the terrain associated with sensitivities
Normal storage use. Do not use if tamper-evident seal is broken or removed.
Choline chloride (15X, 200K), Histamine (15X, 200K), Serotonin (15X, 200K), Adrenal gland (200K), Allium Cepa (200K), Ammonium carbonicum (200K), Apis (200K), Arsenicum album (200K), Lungs (200K), Mucosa (200K), Natrium Mur (200K), Sabadila (200K), Thymus (200K), Adrenalinum (30K), Luffa operculata (30K), Peyer's Patches (30K), Interferon gamma (9X, 200K), Interleukin-12 (10X, 200K), Manganese gluconate (4X)
| Choline chloride | Mental clarity |
| Adrenal gland | Adrenal support |
| Adrenalinum | Adrenal support |
| Allium cepa | Drainage |
| Ammonium carbonicum | Drainage |
| Apis | Inflammation |
| Arsenicum album | Constitution support |
| Histamine | IG support |
| Interferon gamma | Immune support |
| Interleukin-12 | Immune support |
| Manganese gluconate | Oligo support |
| Luffa operculata | Reactional support |
| Lungs | Respiratory support |
| Mucosa | Respiratory support |
| Natrium Muraticum | Constitutional |
| Peyer's Patch | Immune support |
| Sabadila | symptom relief |
| Serotonin | Neurological support |
| Thymus | Immune support |
To assist with balancing the terrain associated with sensitivities
Stop use and ask a health care practitioner if symptoms persist for more than five days or worsen. If pregnant or breastfeeding, ask a health care practitioner before use.
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Keep this and all medicines out of reach of children.
20% Alcohol and 80% Water.
Normal storage use.
Do not use if tamper-evident seal is broken or removed.
info@viatrexx.com
ITEM: VPC0019
NDC 63776-027-15
Homeopathic remedy
Aller Balance
• To assist with balancing the terrain associated with sensitivities
Oral spray
50ml 1.7 oz
Viatrexx™ Bio Incorporated
Manufactured by Viatrexx
www.viatrexx.com
Newark, DE 19713

Aller Balance
50 ml
1.7 oz
Viatrexx™ Bio Incorporated
ITEM: VPC0019
NDC: 63776-027-15
INDICATIONS:
To assit with balancing the terrain associated with sensitivities.
DIRECTIONS:
1-5 spray(s); 1-3 time(s) per day or as recommended by your health care practitioner.
Mfg. for
Viatrexx Bio Incorporated.
www.viatrexx.com
Newark, DE 19713

| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 63776-027-15 | 2024-01-30 | C162847 | 48780-1 | 1030e364-fbe0-111a-e063-dadaa90a10e2 | Aller Balance |
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63776-027-15 | Aller Balance | 1 in 1 BOX | SPRAY | 1 | 6 | |
| 63776-027-15 | Aller Balance | 50 mL in 1 BOTTLE, SPRAY | SPRAY | 50 | 6 |
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63776-027 | ALLER BALANCE (CHOLINE CHLORIDE, BOS TAURUS ADRENAL GLAND, SUS SCROFA ADRENAL GLAND, EPINEPHRINE, ONION, AMMONIUM CARBONATE, APIS MELLIFERA, ARSENIC TRIOXIDE, HISTAMINE, INTERFERON GAMMA-1A, INTERLEUKIN-12 HUMAN, MANGANESE GLUCONATE, LUFFA OPERCULATA FRUIT, SUS SCROFA LUNG, BEEF LUNG, SUS SCROFA NASAL MUCOSA, BOS TAURUS NASAL MUCOSA, SODIUM CHLORIDE, BOS TAURUS PEYERS PATCH, SUS SCROFA PEYERS PATCH, SCHOENOCAULON OFFICINALE SEED, SEROTONIN, BOS TAURUS THYMUS, SUS SCROFA THYMUS) SPRAY [VIATREXX BIO INCORPORATED] | 6 | Legacy NDC, 2 package rows | 20221201_7e35a2c2-e1be-de39-27ee-f462c3cbbc07.zip |
| Ingredient | Type | UNII | SPL version | Uploaded |
|---|---|---|---|---|
| Acetylcholine Chloride | ACTIVE INGREDIENT | AF73293C2R | 1 | |
| Ammonium Carbonate | ACTIVE INGREDIENT | NJ5VT0FKLJ | 1 | |
| Apis Mellifera | ACTIVE INGREDIENT | 7S82P3R43Z | 1 | |
| Arsenic Trioxide | ACTIVE INGREDIENT | S7V92P67HO | 1 | |
| Beef Lung | ACTIVE INGREDIENT | 2I1RTO1MBR | 1 | |
| Bos Taurus Adrenal Gland | ACTIVE INGREDIENT | M2776SWB29 | 1 | |
| Bos Taurus Nasal Mucosa | ACTIVE INGREDIENT | 343455G79K | 1 | |
| Bos Taurus Peyer's Patch | ACTIVE INGREDIENT | XB9AHC8DW1 | 1 | |
| Bos Taurus Thymus | ACTIVE INGREDIENT | 8XEJ88V2T8 | 1 | |
| Epinephrine | ACTIVE INGREDIENT | YKH834O4BH | 1 | |
| Histamine | ACTIVE INGREDIENT | 820484N8I3 | 1 | |
| Interferon Gamma-1a | ACTIVE INGREDIENT | VC9M78242P | 1 | |
| Interleukin-12 Human | ACTIVE INGREDIENT | 7B590791ER | 1 | |
| Luffa Operculata Fruit | ACTIVE INGREDIENT | C4MO6809HU | 1 | |
| Manganese Gluconate | ACTIVE INGREDIENT | 9YY2F980SV | 1 | |
| Onion | ACTIVE INGREDIENT | 492225Q21H | 1 | |
| Schoenocaulon Officinale Seed | ACTIVE INGREDIENT | 6NAF1689IO | 1 | |
| Serotonin | ACTIVE INGREDIENT | 333DO1RDJY | 1 | |
| Sodium Chloride | ACTIVE INGREDIENT | 451W47IQ8X | 1 | |
| Sus Scrofa Adrenal Gland | ACTIVE INGREDIENT | 398IYQ16YV | 1 | |
| Sus Scrofa Lung | ACTIVE INGREDIENT | 7GL3G1COB3 | 1 | |
| Sus Scrofa Nasal Mucosa | ACTIVE INGREDIENT | ID3Z1X61WY | 1 | |
| Sus Scrofa Peyer's Patch | ACTIVE INGREDIENT | 308LM01C72 | 1 | |
| Sus Scrofa Thymus | ACTIVE INGREDIENT | 7B69B0BD62 | 1 | |
| Acetylcholine | ACTIVE MOIETY | N9YNS0M02X | 1 | |
| Ammonium Cation | ACTIVE MOIETY | 54S68520I4 | 1 | |
| Apis Mellifera | ACTIVE MOIETY | 7S82P3R43Z | 1 | |
| Arsenic Cation (3+) | ACTIVE MOIETY | C96613F5AV | 1 | |
| Beef Lung | ACTIVE MOIETY | 2I1RTO1MBR | 1 | |
| Bos Taurus Adrenal Gland | ACTIVE MOIETY | M2776SWB29 | 1 | |
| Bos Taurus Nasal Mucosa | ACTIVE MOIETY | 343455G79K | 1 | |
| Bos Taurus Peyer's Patch | ACTIVE MOIETY | XB9AHC8DW1 | 1 | |
| Bos Taurus Thymus | ACTIVE MOIETY | 8XEJ88V2T8 | 1 | |
| Chloride Ion | ACTIVE MOIETY | Q32ZN48698 | 1 | |
| Epinephrine | ACTIVE MOIETY | YKH834O4BH | 1 | |
| Histamine | ACTIVE MOIETY | 820484N8I3 | 1 | |
| Interferon Gamma-1a | ACTIVE MOIETY | VC9M78242P | 1 | |
| Interleukin-12 Human | ACTIVE MOIETY | 7B590791ER | 1 | |
| Luffa Operculata Fruit | ACTIVE MOIETY | C4MO6809HU | 1 | |
| Manganese Cation (2+) | ACTIVE MOIETY | H6EP7W5457 | 1 | |
| Onion | ACTIVE MOIETY | 492225Q21H | 1 | |
| Schoenocaulon Officinale Seed | ACTIVE MOIETY | 6NAF1689IO | 1 | |
| Serotonin | ACTIVE MOIETY | 333DO1RDJY | 1 | |
| Sus Scrofa Adrenal Gland | ACTIVE MOIETY | 398IYQ16YV | 1 | |
| Sus Scrofa Lung | ACTIVE MOIETY | 7GL3G1COB3 | 1 | |
| Sus Scrofa Nasal Mucosa | ACTIVE MOIETY | ID3Z1X61WY | 1 | |
| Sus Scrofa Peyer's Patch | ACTIVE MOIETY | 308LM01C72 | 1 | |
| Sus Scrofa Thymus | ACTIVE MOIETY | 7B69B0BD62 | 1 | |
| Alcohol | INACTIVE INGREDIENT | 3K9958V90M | 1 | |
| Water | INACTIVE INGREDIENT | 059QF0KO0R | 1 |
Every source-derived product name is available through these pages.
| Product NDC | Package NDC |
|---|---|
| 63776-027 | 63776-027-15 |
Every source-derived ingredient row is available through these pages.
Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.
| DailyMed ingredient | IID ingredient | UNII | Dosage form / route | Potency | Maximum daily exposure | Match |
|---|---|---|---|---|---|---|
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE, EXTENDED RELEASE / ORAL | 8 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SWAB / TOPICAL | 2250 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | ELIXIR / ORAL | 13675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | POWDER, FOR SOLUTION / TOPICAL | 40 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / BUCCAL | 679 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / ORAL | 681 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TOPICAL | 541 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAVENOUS | 6405 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / SUBCUTANEOUS | 149 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / ORAL | 150.68 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | MOUTHWASH / BUCCAL | 200 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | LOTION / TOPICAL | 25 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / ORAL | 6624 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION, CONCENTRATE / INTRAVENOUS | 4000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVESICAL | 7892 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / RESPIRATORY (INHALATION) | 26664 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY, METERED / SUBLINGUAL | 29 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVENOUS | 92 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / RESPIRATORY (INHALATION) | 0.08 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / INTRAMUSCULAR | 1000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / ORAL | 3563 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, SOLUTION / SUBCUTANEOUS | 6.1 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAVASCULAR | 100 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / OPHTHALMIC | 0.5 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, SPRAY / RESPIRATORY (INHALATION) | 35.75 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / RESPIRATORY (INHALATION) | 5 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TOPICAL | 2445 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION, EMULSION / INTRAVENOUS | 520 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | INJECTION / INTRAMUSCULAR | 1491 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAMUSCULAR | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / TRANSDERMAL | 49.37 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / TOPICAL | 561 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CONCENTRATE / ORAL | 198 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TRANSDERMAL | 90 %w/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / TOPICAL | 3633 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / RECTAL | 898 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / NASAL | 10 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / DENTAL | 12.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | DROPS / ORAL | 210 mg/1ml | ||
| Alcohol | ALCOHOL | 3K9958V90M | SUSPENSION / RECTAL | 0.35 %v/v | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL / NASAL | 20 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TRANSDERMAL | 7360 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, METERED / NASAL | 70 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | JELLY / VAGINAL | NA | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL / TOPICAL | 9971 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SHAMPOO / TOPICAL | 714 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SPRAY / SUBLINGUAL | 397 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | LIQUID / INTRAVENOUS | 400 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | GEL, METERED / TRANSDERMAL | 3675 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SYRUP / ORAL | 21000 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | CAPSULE / ORAL | 882 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | AEROSOL, FOAM / TOPICAL | 4504 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | SOLUTION / INTRAVENOUS | 99 mg | ||
| Alcohol | ALCOHOL | 3K9958V90M | PASTE / DENTAL | 1.8 %w/w | ||
| Alcohol | ALCOHOL | 3K9958V90M | TABLET, DELAYED RELEASE / ORAL | NA |
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| eeb4c95c-603c-49d5-e053-2995a90aecbd | 7e35a2c2-e1be-de39-27ee-f462c3cbbc07 | 2022-11-30 | Warnings | eeb4c95c-603c-49d5-e053-2995a90aecbd 7e35a2c2-e1be-de39-27ee-f462c3cbbc07 |
Adverse event summaries are temporarily unavailable. Other product information remains available.